- Chlorambucil
-
Chlorambucil Systematic (IUPAC) name 4-[bis(2-chlorethyl)amino]benzenebutanoic acid Clinical data Trade names Leukeran AHFS/Drugs.com monograph MedlinePlus a682899 Pregnancy cat. D(US) Legal status ℞ Prescription only Routes Oral Pharmacokinetic data Bioavailability ? Metabolism Hepatic Half-life 1.5 hours Excretion N/A Identifiers CAS number 305-03-3 ATC code L01AA02 PubChem CID 2708 DrugBank APRD00115 ChemSpider 2607 UNII 18D0SL7309 KEGG D00266 ChEBI CHEBI:28830 ChEMBL CHEMBL515 Chemical data Formula C14H19Cl2NO2 Mol. mass 304.212 g/mol SMILES eMolecules & PubChem (what is this?) (verify) Chlorambucil (marketed as Leukeran by GlaxoSmithKline) is a chemotherapy drug that has been mainly used in the treatment of chronic lymphocytic leukemia. It is a nitrogen mustard alkylating agent[1] and can be given orally.
In the past, chlorambucil has been used for treating some types of non-Hodgkin lymphoma, Waldenström macroglobulinemia, polycythemia vera, trophoblastic neoplasms, and ovarian carcinoma. It also has been used as an immunosuppressive drug for various autoimmune and inflammatory conditions, such as nephrotic syndrome. Its current use is mainly in chronic lymphocytic leukemia, as it is well tolerated by most patients, though chlorambucil has been largely replaced by fludarabine as first-line treatment in younger patients.[2]
Side Effects
Bone marrow suppression (anemia, neutropenia, thrombocytopenia) is the most commonly occurring side effect of chlorambucil. Withdrawn from the drug, this side effect is typically reversible. Like many alkylating agents, chlorambucil has been associated with the development of other forms of cancer.
Less commonly occurring side effects include:
- Gastrointestinal Distress (nausea, vomiting, diarrhea, and oral ulcerations).
- Central Nervous System: Seizures, tremors, muscular twitching, confusion, agitation, ataxia, and hallucinations.
- Skin reactions
- Hepatotoxicity
- Infertility
References
- ^ Takimoto CH, Calvo E. "Principles of Oncologic Pharmacotherapy" in Pazdur R, Wagman LD, Camphausen KA, Hoskins WJ (Eds) Cancer Management: A Multidisciplinary Approach. 11 ed. 2008.
- ^ Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA (2000). "Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.". N Engl J Med 343 (24): 1750–7. doi:10.1056/NEJM200012143432402. PMID 11114313.
External links
- Leukeran (manufacturer's website)
- MedlinePlus's Drug Information
Categories:- IARC Group 1 carcinogens
- Alkylating antineoplastic agents
- Anilines
- Organochlorides
- Nitrogen mustards
Wikimedia Foundation. 2010.